Review



non immune mouse igg2a  (Bio-Rad)


Bioz Verified Symbol Bio-Rad is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Bio-Rad non immune mouse igg2a
    Fig. 2 Changes in plasma concentration of the OX26 and <t>Ni-IgG2a</t> with time after injection expressed as % ID/mL plasma ^ SD in adult (a) and P15 (b) rats. Initially, the concentration of OX26 decreases markedly to a signi®cantly lower concentration than Ni-IgG2a, and from 2 min and onwards, the plasma concentration of OX26 and Ni-IgG2a are statistically different at any time point. The diamonds marked by an arrow represent the corresponding values of OX26 and Ni-IgG2a (identical colour) of iron-de®cient P15 rats; these values are not statistically different to the corresponding values of P15 rats having a normal iron status. Each value is the mean ^ SD of measurements from 3 to 5 rats. A, OX26; B, Ni-Ig2a.
    Non Immune Mouse Igg2a, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 94/100, based on 538 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/non+immune+mouse+igg2a/Rat+anti+Mouse+IgG2b/pm11595764-38-9-16
    Average 94 stars, based on 538 article reviews
    non immune mouse igg2a - by Bioz Stars, 2026-09
    94/100 stars

    Images

    1) Product Images from "Restricted transport of anti-transferrin receptor antibody (OX26) through the blood-brain barrier in the rat."

    Article Title: Restricted transport of anti-transferrin receptor antibody (OX26) through the blood-brain barrier in the rat.

    Journal: Journal of neurochemistry

    doi: 10.1046/j.1471-4159.2001.00541.x

    Fig. 2 Changes in plasma concentration of the OX26 and Ni-IgG2a with time after injection expressed as % ID/mL plasma ^ SD in adult (a) and P15 (b) rats. Initially, the concentration of OX26 decreases markedly to a signi®cantly lower concentration than Ni-IgG2a, and from 2 min and onwards, the plasma concentration of OX26 and Ni-IgG2a are statistically different at any time point. The diamonds marked by an arrow represent the corresponding values of OX26 and Ni-IgG2a (identical colour) of iron-de®cient P15 rats; these values are not statistically different to the corresponding values of P15 rats having a normal iron status. Each value is the mean ^ SD of measurements from 3 to 5 rats. A, OX26; B, Ni-Ig2a.
    Figure Legend Snippet: Fig. 2 Changes in plasma concentration of the OX26 and Ni-IgG2a with time after injection expressed as % ID/mL plasma ^ SD in adult (a) and P15 (b) rats. Initially, the concentration of OX26 decreases markedly to a signi®cantly lower concentration than Ni-IgG2a, and from 2 min and onwards, the plasma concentration of OX26 and Ni-IgG2a are statistically different at any time point. The diamonds marked by an arrow represent the corresponding values of OX26 and Ni-IgG2a (identical colour) of iron-de®cient P15 rats; these values are not statistically different to the corresponding values of P15 rats having a normal iron status. Each value is the mean ^ SD of measurements from 3 to 5 rats. A, OX26; B, Ni-Ig2a.

    Techniques Used: Clinical Proteomics, Concentration Assay, Injection

    Fig. 3 Accumulation of OX26 and Ni-IgG2a expressed as % ID/organ ^ SD in adult brain (a) and adult liver (b). The accumu- lation of both OX26 and Ni-IgG2a is much higher in the liver than in the brain (*). At 60 min, the accumulation of OX26 in the brain is signi®cantly higher than at 30 min post-injection. A, OX26; B, Ni-Ig2a.
    Figure Legend Snippet: Fig. 3 Accumulation of OX26 and Ni-IgG2a expressed as % ID/organ ^ SD in adult brain (a) and adult liver (b). The accumu- lation of both OX26 and Ni-IgG2a is much higher in the liver than in the brain (*). At 60 min, the accumulation of OX26 in the brain is signi®cantly higher than at 30 min post-injection. A, OX26; B, Ni-Ig2a.

    Techniques Used: Injection

    Fig. 6 Accumulation of OX26 and Ni-IgG2a in CSF of adult and P15 rats expressed as % ID/mL CSF 1 SD (a) or Vd expressed as mL plasma/mL CSF 1 SD (b). (a) The uptake of both proteins are signi®cantly higher in the P15 rat than in the adult (*). OX26 accu- mulates to a signi®cantly higher degree than Ni-IgG2a in both the adult and P15 rat (o). (b) When expressed in terms of Vd, OX26 accumulation is greater than Ni-IgG2a at both ages (o). The Vd values of OX26 and Ni-IgG2a are not statistically different.
    Figure Legend Snippet: Fig. 6 Accumulation of OX26 and Ni-IgG2a in CSF of adult and P15 rats expressed as % ID/mL CSF 1 SD (a) or Vd expressed as mL plasma/mL CSF 1 SD (b). (a) The uptake of both proteins are signi®cantly higher in the P15 rat than in the adult (*). OX26 accu- mulates to a signi®cantly higher degree than Ni-IgG2a in both the adult and P15 rat (o). (b) When expressed in terms of Vd, OX26 accumulation is greater than Ni-IgG2a at both ages (o). The Vd values of OX26 and Ni-IgG2a are not statistically different.

    Techniques Used: Clinical Proteomics

    Related Articles

    Clinical Proteomics:

    Article Title: Restricted transport of anti-transferrin receptor antibody (OX26) through the blood-brain barrier in the rat.
    Article Snippet: Puri®ed monoclonal mouse-anti-rat transferrin receptor IgG2a (clone OX26) and non-immune mouse IgG2a (Ni-IgG2a) were purchased from Serotec (Oxford, UK).

    Concentration Assay:

    Article Title: Restricted transport of anti-transferrin receptor antibody (OX26) through the blood-brain barrier in the rat.
    Article Snippet: Puri®ed monoclonal mouse-anti-rat transferrin receptor IgG2a (clone OX26) and non-immune mouse IgG2a (Ni-IgG2a) were purchased from Serotec (Oxford, UK).

    Injection:

    Article Title: Restricted transport of anti-transferrin receptor antibody (OX26) through the blood-brain barrier in the rat.
    Article Snippet: Puri®ed monoclonal mouse-anti-rat transferrin receptor IgG2a (clone OX26) and non-immune mouse IgG2a (Ni-IgG2a) were purchased from Serotec (Oxford, UK).



    Similar Products

    93
    R&D Systems non immune mouse igg
    Non Immune Mouse Igg, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/non+immune+mouse+igg2a/Rat+Anti-Mouse+IgG2A+PE-conjugated+Antibody/pmc05505057-35-18-21
    Average 93 stars, based on 1 article reviews
    non immune mouse igg - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    91
    R&D Systems non immunized mouse igg2a
    VDR is expressed by BMSCs, osteoblasts, osteocytes, chondrocytes, and osteoclasts in bone tissue. Serial sections of human bone samples, right column; hematoxylin and eosin staining, middle column; negative staining <t>(IgG),</t> left column; IHC of VDR ( a – c ), and (d) Cathepsin K (CATK). Positive cross-reactivity of VDR was observed in bone lining osteoblasts (black arrows in a), newly embedded osteocytes (white arrows in a), adipocytes (red arrows in a), chondrocytes (black arrows in b), bone resorbing multinucleated osteoclast (black arrow in c). Negative cross-reactivity was observed in mature osteocytes (red arrows in c).
    Non Immunized Mouse Igg2a, supplied by R&D Systems, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/non+immune+mouse+igg2a/Rat+anti-Mouse+IgG2a+Heavy+Chain+Secondary+Antibody+(LO-MG2a-7)/pmc05057180-51-21-26
    Average 91 stars, based on 1 article reviews
    non immunized mouse igg2a - by Bioz Stars, 2026-09
    91/100 stars
      Buy from Supplier

    90
    Agilent technologies non-immune mouse isotype igg2a
    VDR is expressed by BMSCs, osteoblasts, osteocytes, chondrocytes, and osteoclasts in bone tissue. Serial sections of human bone samples, right column; hematoxylin and eosin staining, middle column; negative staining <t>(IgG),</t> left column; IHC of VDR ( a – c ), and (d) Cathepsin K (CATK). Positive cross-reactivity of VDR was observed in bone lining osteoblasts (black arrows in a), newly embedded osteocytes (white arrows in a), adipocytes (red arrows in a), chondrocytes (black arrows in b), bone resorbing multinucleated osteoclast (black arrow in c). Negative cross-reactivity was observed in mature osteocytes (red arrows in c).
    Non Immune Mouse Isotype Igg2a, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/non+immune+mouse+igg2a/pm12483411-76-27-31
    Average 90 stars, based on 1 article reviews
    non-immune mouse isotype igg2a - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    94
    Bio-Rad non immune mouse igg2a
    Fig. 2 Changes in plasma concentration of the OX26 and <t>Ni-IgG2a</t> with time after injection expressed as % ID/mL plasma ^ SD in adult (a) and P15 (b) rats. Initially, the concentration of OX26 decreases markedly to a signi®cantly lower concentration than Ni-IgG2a, and from 2 min and onwards, the plasma concentration of OX26 and Ni-IgG2a are statistically different at any time point. The diamonds marked by an arrow represent the corresponding values of OX26 and Ni-IgG2a (identical colour) of iron-de®cient P15 rats; these values are not statistically different to the corresponding values of P15 rats having a normal iron status. Each value is the mean ^ SD of measurements from 3 to 5 rats. A, OX26; B, Ni-Ig2a.
    Non Immune Mouse Igg2a, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/non+immune+mouse+igg2a/Rat+anti+Mouse+IgG2b/pm11595764-38-9-16
    Average 94 stars, based on 1 article reviews
    non immune mouse igg2a - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    Image Search Results


    VDR is expressed by BMSCs, osteoblasts, osteocytes, chondrocytes, and osteoclasts in bone tissue. Serial sections of human bone samples, right column; hematoxylin and eosin staining, middle column; negative staining (IgG), left column; IHC of VDR ( a – c ), and (d) Cathepsin K (CATK). Positive cross-reactivity of VDR was observed in bone lining osteoblasts (black arrows in a), newly embedded osteocytes (white arrows in a), adipocytes (red arrows in a), chondrocytes (black arrows in b), bone resorbing multinucleated osteoclast (black arrow in c). Negative cross-reactivity was observed in mature osteocytes (red arrows in c).

    Journal: Bone Research

    Article Title: Vitamin D receptor expression in human bone tissue and dose-dependent activation in resorbing osteoclasts

    doi: 10.1038/boneres.2016.30

    Figure Lengend Snippet: VDR is expressed by BMSCs, osteoblasts, osteocytes, chondrocytes, and osteoclasts in bone tissue. Serial sections of human bone samples, right column; hematoxylin and eosin staining, middle column; negative staining (IgG), left column; IHC of VDR ( a – c ), and (d) Cathepsin K (CATK). Positive cross-reactivity of VDR was observed in bone lining osteoblasts (black arrows in a), newly embedded osteocytes (white arrows in a), adipocytes (red arrows in a), chondrocytes (black arrows in b), bone resorbing multinucleated osteoclast (black arrow in c). Negative cross-reactivity was observed in mature osteocytes (red arrows in c).

    Article Snippet: For general morphological analysis, decalcified sections were stained with Mayer’s hematoxylin and eosin, and negative control sections were incubated with the non-immunized mouse IgG2a and IgG1 (R&D Systems, UK).

    Techniques: Staining, Negative Staining

    Fig. 2 Changes in plasma concentration of the OX26 and Ni-IgG2a with time after injection expressed as % ID/mL plasma ^ SD in adult (a) and P15 (b) rats. Initially, the concentration of OX26 decreases markedly to a signi®cantly lower concentration than Ni-IgG2a, and from 2 min and onwards, the plasma concentration of OX26 and Ni-IgG2a are statistically different at any time point. The diamonds marked by an arrow represent the corresponding values of OX26 and Ni-IgG2a (identical colour) of iron-de®cient P15 rats; these values are not statistically different to the corresponding values of P15 rats having a normal iron status. Each value is the mean ^ SD of measurements from 3 to 5 rats. A, OX26; B, Ni-Ig2a.

    Journal: Journal of neurochemistry

    Article Title: Restricted transport of anti-transferrin receptor antibody (OX26) through the blood-brain barrier in the rat.

    doi: 10.1046/j.1471-4159.2001.00541.x

    Figure Lengend Snippet: Fig. 2 Changes in plasma concentration of the OX26 and Ni-IgG2a with time after injection expressed as % ID/mL plasma ^ SD in adult (a) and P15 (b) rats. Initially, the concentration of OX26 decreases markedly to a signi®cantly lower concentration than Ni-IgG2a, and from 2 min and onwards, the plasma concentration of OX26 and Ni-IgG2a are statistically different at any time point. The diamonds marked by an arrow represent the corresponding values of OX26 and Ni-IgG2a (identical colour) of iron-de®cient P15 rats; these values are not statistically different to the corresponding values of P15 rats having a normal iron status. Each value is the mean ^ SD of measurements from 3 to 5 rats. A, OX26; B, Ni-Ig2a.

    Article Snippet: Puri®ed monoclonal mouse-anti-rat transferrin receptor IgG2a (clone OX26) and non-immune mouse IgG2a (Ni-IgG2a) were purchased from Serotec (Oxford, UK).

    Techniques: Clinical Proteomics, Concentration Assay, Injection

    Fig. 3 Accumulation of OX26 and Ni-IgG2a expressed as % ID/organ ^ SD in adult brain (a) and adult liver (b). The accumu- lation of both OX26 and Ni-IgG2a is much higher in the liver than in the brain (*). At 60 min, the accumulation of OX26 in the brain is signi®cantly higher than at 30 min post-injection. A, OX26; B, Ni-Ig2a.

    Journal: Journal of neurochemistry

    Article Title: Restricted transport of anti-transferrin receptor antibody (OX26) through the blood-brain barrier in the rat.

    doi: 10.1046/j.1471-4159.2001.00541.x

    Figure Lengend Snippet: Fig. 3 Accumulation of OX26 and Ni-IgG2a expressed as % ID/organ ^ SD in adult brain (a) and adult liver (b). The accumu- lation of both OX26 and Ni-IgG2a is much higher in the liver than in the brain (*). At 60 min, the accumulation of OX26 in the brain is signi®cantly higher than at 30 min post-injection. A, OX26; B, Ni-Ig2a.

    Article Snippet: Puri®ed monoclonal mouse-anti-rat transferrin receptor IgG2a (clone OX26) and non-immune mouse IgG2a (Ni-IgG2a) were purchased from Serotec (Oxford, UK).

    Techniques: Injection

    Fig. 6 Accumulation of OX26 and Ni-IgG2a in CSF of adult and P15 rats expressed as % ID/mL CSF 1 SD (a) or Vd expressed as mL plasma/mL CSF 1 SD (b). (a) The uptake of both proteins are signi®cantly higher in the P15 rat than in the adult (*). OX26 accu- mulates to a signi®cantly higher degree than Ni-IgG2a in both the adult and P15 rat (o). (b) When expressed in terms of Vd, OX26 accumulation is greater than Ni-IgG2a at both ages (o). The Vd values of OX26 and Ni-IgG2a are not statistically different.

    Journal: Journal of neurochemistry

    Article Title: Restricted transport of anti-transferrin receptor antibody (OX26) through the blood-brain barrier in the rat.

    doi: 10.1046/j.1471-4159.2001.00541.x

    Figure Lengend Snippet: Fig. 6 Accumulation of OX26 and Ni-IgG2a in CSF of adult and P15 rats expressed as % ID/mL CSF 1 SD (a) or Vd expressed as mL plasma/mL CSF 1 SD (b). (a) The uptake of both proteins are signi®cantly higher in the P15 rat than in the adult (*). OX26 accu- mulates to a signi®cantly higher degree than Ni-IgG2a in both the adult and P15 rat (o). (b) When expressed in terms of Vd, OX26 accumulation is greater than Ni-IgG2a at both ages (o). The Vd values of OX26 and Ni-IgG2a are not statistically different.

    Article Snippet: Puri®ed monoclonal mouse-anti-rat transferrin receptor IgG2a (clone OX26) and non-immune mouse IgG2a (Ni-IgG2a) were purchased from Serotec (Oxford, UK).

    Techniques: Clinical Proteomics